Skip to main content
Top
Published in: Cancer Causes & Control 3/2012

01-03-2012 | Original paper

Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study

Authors: Nghi B. Ha, Nghiem B. Ha, Aijaz Ahmed, Walid Ayoub, Tami J. Daugherty, Ellen T. Chang, Glen A. Lutchman, Gabriel Garcia, Allen D. Cooper, Emmet B. Keeffe, Mindie H. Nguyen

Published in: Cancer Causes & Control | Issue 3/2012

Login to get access

Abstract

The majority of data on risk factors (RFs) for hepatocellular carcinoma (HCC) comes from studies involving populations without underlying liver disease. It is important to evaluate RFs for HCC in patients with chronic liver disease since HCC rarely occurs in those without underlying liver disease. We conducted a hospital-based case–control study of 259 incident HCC cases and 781 controls by convenience sampling between 02/2001 and 12/2009 from the liver clinic at Stanford University Medical Center. The study population was 41% White, 14% Hispanic, 3% African American, 40% Asian American, and 2% other race/ethnicity. RFs were examined through medical records and an in-person questionnaire. Alcohol and tobacco use was calculated by cumulative grams of alcohol or cumulative pack(s) of cigarette consumed over one’s lifetime. Diabetes mellitus (DM) was defined by random glucose level of ≥200 mg/dL. RFs were evaluated using multivariate logistic regression. Independent predictors of HCC risk, after mutual adjustment and additional control for alcohol use, etiology of liver diseases, and DM, included age >40 (OR = 8.5 [2.6–28.3]), male gender (OR = 3.5 [2.2–5.8]), presence of cirrhosis (OR = 2.8 [1.6–4.9]), Asian ethnicity (OR = 2.8 [1.8–4.6]), AFP > 50 (OR = 4.2 [2.6–6.8]), and cumulative lifetime tobacco use of >11,000 packs (OR = 1.7 [1.0–2.9]). Heavy prolonged cigarette smoking, but not alcohol use, was a significant independent predictor for HCC in patients with underlying liver disease. Besides older age, male gender, presence of cirrhosis, and elevated AFP, Asian ethnicity and heavy cumulative tobacco use are strong independent predictors of HCC.
Literature
2.
go back to reference Mazzanti R, Gramantieri L, Bolondi L (2008) Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med 29:130–143PubMedCrossRef Mazzanti R, Gramantieri L, Bolondi L (2008) Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med 29:130–143PubMedCrossRef
3.
go back to reference El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576PubMedCrossRef El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576PubMedCrossRef
4.
5.
go back to reference Kanwal F, El-Serag HB (2009) Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol 50:10–12PubMedCrossRef Kanwal F, El-Serag HB (2009) Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol 50:10–12PubMedCrossRef
6.
go back to reference Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:323–331PubMedCrossRef Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:323–331PubMedCrossRef
7.
go back to reference Di Bisceglie AM, Lyra AC, Schwartz M et al (2003) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98:2060–2063PubMedCrossRef Di Bisceglie AM, Lyra AC, Schwartz M et al (2003) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98:2060–2063PubMedCrossRef
8.
go back to reference Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044PubMedCrossRef Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044PubMedCrossRef
9.
go back to reference El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127:S27–S34PubMedCrossRef El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127:S27–S34PubMedCrossRef
10.
go back to reference Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300–4308PubMedCrossRef Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300–4308PubMedCrossRef
11.
go back to reference Nguyen MH, Whittemore AS, Garcia RT et al (2004) Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol 2:820–824PubMedCrossRef Nguyen MH, Whittemore AS, Garcia RT et al (2004) Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol 2:820–824PubMedCrossRef
12.
go back to reference Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD (1999) Ethnic differences in the behavior of hepatocellular carcinoma. Cancer 85:1931–1936PubMed Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD (1999) Ethnic differences in the behavior of hepatocellular carcinoma. Cancer 85:1931–1936PubMed
13.
go back to reference Hassan MM, Hwang LY, Hatten CJ et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36:1206–1213PubMedCrossRef Hassan MM, Hwang LY, Hatten CJ et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36:1206–1213PubMedCrossRef
14.
go back to reference Mukaiya M, Nishi M, Miyake H, Hirata K (1998) Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 45:2328–2332PubMed Mukaiya M, Nishi M, Miyake H, Hirata K (1998) Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 45:2328–2332PubMed
15.
go back to reference Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R (2003) Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 107:106–112PubMedCrossRef Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R (2003) Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 107:106–112PubMedCrossRef
16.
go back to reference Mizoue T, Tokui N, Nishisaka K et al (2000) Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol 29:232–237PubMedCrossRef Mizoue T, Tokui N, Nishisaka K et al (2000) Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol 29:232–237PubMedCrossRef
17.
go back to reference Tanaka K, Hirohata T, Takeshita S et al (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka. Jpn Int J Cancer 51:509–514CrossRef Tanaka K, Hirohata T, Takeshita S et al (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka. Jpn Int J Cancer 51:509–514CrossRef
18.
go back to reference La Vecchia C, Negri E, Decarli A, D’Avanzo B, Franceschi S (1988) Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 42:872–876PubMed La Vecchia C, Negri E, Decarli A, D’Avanzo B, Franceschi S (1988) Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 42:872–876PubMed
19.
go back to reference Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11:369–376PubMed Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11:369–376PubMed
20.
go back to reference El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369–380PubMedCrossRef El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369–380PubMedCrossRef
21.
go back to reference Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN (2010) Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol PMID:20054698 Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN (2010) Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol PMID:20054698
22.
go back to reference Pattullo V, Heathcote J (2009) Hepatitis C and diabetes: one treatment for two diseases? Liver Int PMID:20040049 Pattullo V, Heathcote J (2009) Hepatitis C and diabetes: one treatment for two diseases? Liver Int PMID:20040049
23.
go back to reference Patel P, Macerollo A (2010) Diabetes mellitus: diagnosis and screening. Am Fam Physician 81:863–870PubMed Patel P, Macerollo A (2010) Diabetes mellitus: diagnosis and screening. Am Fam Physician 81:863–870PubMed
24.
go back to reference El-Serag HB (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37(Suppl 2):S88–S94PubMedCrossRef El-Serag HB (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37(Suppl 2):S88–S94PubMedCrossRef
25.
go back to reference Kuper H, Tzonou A, Kaklamani E et al (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85:498–502PubMedCrossRef Kuper H, Tzonou A, Kaklamani E et al (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85:498–502PubMedCrossRef
26.
go back to reference Zhu K, Moriarty C, Caplan LS, Levine RS (2007) Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control 18:315–321PubMedCrossRef Zhu K, Moriarty C, Caplan LS, Levine RS (2007) Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control 18:315–321PubMedCrossRef
27.
go back to reference Jee SH, Ohrr H, Sull JW, Samet JM (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851–1856PubMedCrossRef Jee SH, Ohrr H, Sull JW, Samet JM (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851–1856PubMedCrossRef
28.
go back to reference Fujita Y, Shibata A, Ogimoto I et al (2006) The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 94:737–739PubMedCrossRef Fujita Y, Shibata A, Ogimoto I et al (2006) The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 94:737–739PubMedCrossRef
29.
go back to reference Wang LY, You SL, Lu SN et al (2003) Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14:241–250PubMedCrossRef Wang LY, You SL, Lu SN et al (2003) Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14:241–250PubMedCrossRef
30.
go back to reference Hassan MM, Spitz MR, Thomas MB et al (2008) Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 123:1883–1891PubMedCrossRef Hassan MM, Spitz MR, Thomas MB et al (2008) Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 123:1883–1891PubMedCrossRef
31.
go back to reference Wong CR, Garcia RT, Trinh HN et al (2009) Adherence to Screening for Hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci PMID:19876735 Wong CR, Garcia RT, Trinh HN et al (2009) Adherence to Screening for Hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci PMID:19876735
Metadata
Title
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study
Authors
Nghi B. Ha
Nghiem B. Ha
Aijaz Ahmed
Walid Ayoub
Tami J. Daugherty
Ellen T. Chang
Glen A. Lutchman
Gabriel Garcia
Allen D. Cooper
Emmet B. Keeffe
Mindie H. Nguyen
Publication date
01-03-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9895-z

Other articles of this Issue 3/2012

Cancer Causes & Control 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine